| Theme | The State of the Art in Chemotherapy for Gastrointestinal Cancer | |
|---|---|---|
| Title | Molecular Targeted Therapy for Advanced Gastric Cancer | |
| Publish Date | 2011/06 | |
| Author | Yoshito Komatsu | Hokkaido University Hospital Cancer Center, Department of Cancer Chemotherapy |
| Author | Satoshi Yuki | Hokkaido University Hospital Cancer Center, Department of Cancer Chemotherapy |
| Author | Yoshimitsu Kobayashi | Hokkaido University Hospital Cancer Center, Department of Cancer Chemotherapy |
| Author | Hiroshi Nakatsumi | Hokkaido University Hospital Cancer Center, Department of Cancer Chemotherapy |
| Author | Hiraku Fukushima | Hokkaido University Hospital Cancer Center, Department of Cancer Chemotherapy |
| Author | Susumu Sogabe | Hokkaido University Hospital Cancer Center, Department of Cancer Chemotherapy |
| Author | Masahiro Asaka | Hokkaido University Hospital Cancer Center, Department of Cancer Chemotherapy |
| [ Summary ] | Many clinical trials concerning advanced gastric cancer treatment have been performed to develop molecular targeted therapies. We refer to molecular targeted therapies which are in the clinical trial stage at this time. We also explain the ToGA trial and the implementation of the agent trastuzumab, which will be approved for use this year in Japan. | |